C. Vetter

发表

Tumor stroma-associated antigens for anti-cancer immunotherapy

J. Becker, E. Bröcker, D. Schrama, 2006, Cancer Immunology, Immunotherapy.

B-Raf specific antibody responses in melanoma patients

J. Becker, E. Bröcker, U. Rapp, 2004, BMC Cancer.

Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.

J. Becker, E. Bröcker, J. Zeuthen, 2000, The Journal of investigative dermatology.

Expression of stress-induced MHC class I related chain molecules on human melanoma.

J. Becker, E. Bröcker, T. Spies, 2002, The Journal of investigative dermatology.

Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.

J. Becker, L. Pedersen, E. Bröcker, 2002, The Journal of investigative dermatology.

CD28‐mediated costimulation impacts on the differentiation of DC vaccination‐induced T cell responses

J. Becker, D. Schrama, H. Reichardt, 2006, Clinical and experimental immunology.

Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions

J. Becker, E. Bröcker, D. Schrama, 2005, Archives of Dermatological Research.

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report

J. Becker, E. Bröcker, R. Houben, 2006, BMC Cancer.

Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma

J. Becker, E. Bröcker, C. Vetter, 2004, British Journal of Cancer.

Differential expression of CD28 and CD94 / NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node

J. Becker, E. Bröcker, D. Schrama, 2000, European journal of immunology.

STAT5 Contributes to Interferon Resistance of Melanoma Cells

J. Becker, M. Schartl, P. Heinrich, 2005, Current Biology.